Update Interview with New CEO Brent Charleton Reveals Significant Potential for EnWave Corp

We’re very pleased to have Mr. Brent Charleton with us today, the brand new President and CEO of EnWave Corporation (TSXV:ENW – $1.24 CAD & OTC:NWVCF – $0.95 USD & Frankfurt:E4U – €0.81), to give us an update on his Company.

Mr. Charleton first discusses the departure of Dr. Durance as CEO last month and thoroughly explains what happens with the Company’s patents now that Dr. Durance is no longer with the Company.

In addition, Mr. Charleton delivers plenty of valuable information about EnWave’s pharmaceutical business. He talks about what went wrong with Sutro Biopharma, the excellent recent news from Merck, and how the potential collaboration with GEA could be a big win for both companies.

The interview also digs deeper into the Company’s developments in the flourishing cannabis industry. The CEO gives an overview of the current deals and negotiations with Tilray and other Canadian Licensed Producers. In addition, he provides more details about other cannabis agreements in the pipeline.

Moreover, a substantial portion of the interview is devoted to NutraDried and its Moon Cheese sales. Investors find out about the market potential for the crunchy cheese snack and new product development at the subsidiary.

Investors also find out more about the partnership with Bonduelle, and the extremely exciting opportunity with the US Army Natick Soldier R&D Center.

Access our interview by clicking the play button on the media player below,
or download our convenient transcript.

For important disclosures, please read our disclaimer.Latest Company Report (pdf)

4 comments

  • Great to listen to another informative interview. I think Brent will be well suited in his new role as CEO and hopefully shareholders will see all of ENW’s efforts come to fruition in the not so distant future. It was also good to hear that Tim Durance’s departure doesn’t appear to be on as bad terms as I initially thought. This is a fun company to watch and hold.

  • A very nice update!

    One thing I found a little strange: Enwave is becoming less and less of a major milestone company.
    When for example Bonduelle orders a 300 or 400 machine then this single order is more then the whole 2018 machinery sales. So far me this news would be huge. Also keeping in mind the royalties that will follow.

    • John Peters (editor)

      Hi Els,

      You’re right. Also getting a juicy contract from the US armed forces would certainly be a big milestone for the company. But of course, the more clients EnWave has, the less impact a new one will have on the total.

      Cheers,

      John

Leave a Reply

Your email address will not be published.